Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed to treat diabetes and obesity, but research has found evidence that they may also have behavioral effects, including supporting impulse control and reducing substance use and alcohol intake, by potentially interacting with the brain’s reward and stress systems. new research in criminology It adds to this growing body of evidence.
Researchers analyzed data from a 2025 nationally representative US survey of 821 adults who had ever used GLP-1 drugs and found that while impulsivity and alcohol use were strongly associated with violent crime, these associations were significantly weaker among current GLP-1 RA users compared to former users. Therefore, even if a GLP-1 RA user drinks alcohol or acts impulsively, the situation is less likely to escalate into a violent crime. A more thorough analysis showed that this finding was particularly consistent with respect to impulsivity, but less so with respect to alcohol use.
The results of this study suggest that GLP-1 RAs may reduce the extent to which certain established risk factors lead to violent behavior.
As GLP-1 drugs become increasingly popular, understanding their widespread behavioral effects has become an important public health and criminological issue that requires careful study. ”
Dr. Daniel C. Semenza, Corresponding Author, Rutgers University
sauce:
Reference magazines:
Semenza DC, Thomas C. (2026). Glucagon-like peptide-1 receptor agonist use and violent crime among US adults. criminology. DOI: 10.1111/1745-9125.70058. https://onlinelibrary.wiley.com/doi/abs/10.1111/1745-9125.70058
